Upregulated histamine receptor H3 promotes tumor growth and metastasis in hepatocellular carcinoma.

Abstract:

:Histamine receptor H3 (HRH3) is mainly expressed in the central nervous system, where it is involved in the regulation of the release of various neurotransmitters in the brain. Recent studies have demonstrated that the expression of HRH3 is upregulated in several types of cancer. However, the functional effect of HRH3 on tumor progression remains largely unknown, particularly in hepatocellular carcinoma (HCC). In the present study, the expression of HRH3 in 96 HCC patients was first evaluated, and its clinical significance was analyzed. Subsequently, the functional roles of HRH3 in HCC growth and metastasis were systematically explored in vitro and in vivo using its agonist (imetit) or antagonist (clobenpropit). It was observed that HRH3 was significantly upregulated in HCC tissues, while its expression was significantly associated with recurrence‑free survival and overall survival in HCC patients. Functional experiments also demonstrated that HRH3 upregulation facilitated the growth and metastasis of HCC cells by inducing the formation of lamellipodia. These findings revealed that HRH3 serves an important role in the growth and metastasis of HCC cells, which provides experimental evidence supporting the application of HRH3 as a potential therapeutic target in HCC treatment.

journal_name

Oncol Rep

journal_title

Oncology reports

authors

Yu D,Zhao J,Wang Y,Hu J,Zhao Q,Li J,Zhu J

doi

10.3892/or.2019.7119

subject

Has Abstract

pub_date

2019-06-01 00:00:00

pages

3347-3354

issue

6

eissn

1021-335X

issn

1791-2431

journal_volume

41

pub_type

杂志文章
  • Differential regulation of DEC2 among hypoxia-inducible genes in endometrial carcinomas.

    abstract::In this study, we demonstrate an important role of activation of the hypoxia-inducible factor-1 (HIF-1) pathway in endometrial carcinogenesis and tumor phenotype development of endometrial carcinoma, and suggest a unique role of the HIF-1-target gene, differentiated embryo chondrocyte 2 (DEC2), in carcinogenesis. Hypo...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:

    authors: Yunokawa M,Tanimoto K,Nakamura H,Nagai N,Kudo Y,Kawamoto T,Kato Y,Hiyama E,Hiyama K,Nishiyama M

    更新日期:2007-04-01 00:00:00

  • Methylation of CLDN6, FBN2, RBP1, RBP4, TFPI2, and TMEFF2 in esophageal squamous cell carcinoma.

    abstract::In the development and progression of cancer, tumor suppressor genes may be silenced by mechanisms such as methylation. Thus the discovery of new genes silenced by methylation may uncover new tumor suppressor genes, and improve our understanding of cancer biology. In this study we investigated the methylation of 19 ge...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or_00000325

    authors: Tsunoda S,Smith E,De Young NJ,Wang X,Tian ZQ,Liu JF,Jamieson GG,Drew PA

    更新日期:2009-04-01 00:00:00

  • Inhibition of autophagy enhances the targeted therapeutic effect of sorafenib in thyroid cancer.

    abstract::The multi-target kinase inhibitor sorafenib has been approved for the treatment of patients with advanced differentiated thyroid cancer. However, different sensitivities to sorafenib have been observed, and few patients have benefited from sorafenib treatment in the long term. In the event of acquired resistance to so...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2017.6118

    authors: Yi H,Ye T,Ge M,Yang M,Zhang L,Jin S,Ye X,Long B,Li L

    更新日期:2018-02-01 00:00:00

  • Expansion of quiescent lung adenocarcinoma CD8+ T cells by MUC1-8-mer peptide-T2 cell-β2 microglobulin complexes.

    abstract::Adoptive immunotherapy requires the isolation of CD8+ T cells specific for tumor-associated antigens, their expansion in vitro and their transfusion to the patient to mediate a therapeutic effect. MUC1 is an important adenocarcinoma antigen immunogenic for T cells. The MUC1-derived SAPDTRPA (MUC1-8-mer) peptide is a p...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2015.4328

    authors: Atzin-Méndez JA,López-González JS,Báez R,Arenas-Del Angel MC,Montaño LF,Silva-Adaya D,Lascurain R,Gorocica P

    更新日期:2016-01-01 00:00:00

  • Genome-wide DNA methylation analysis in hepatocellular carcinoma.

    abstract::Epigenetic changes as well as genetic changes are mechanisms of tumorigenesis. We aimed to identify novel genes that are silenced by DNA hypermethylation in hepatocellular carcinoma (HCC). We screened for genes with promoter DNA hypermethylation using a genome-wide methylation microarray analysis in primary HCC (the d...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2016.4619

    authors: Yamada N,Yasui K,Dohi O,Gen Y,Tomie A,Kitaichi T,Iwai N,Mitsuyoshi H,Sumida Y,Moriguchi M,Yamaguchi K,Nishikawa T,Umemura A,Naito Y,Tanaka S,Arii S,Itoh Y

    更新日期:2016-04-01 00:00:00

  • Cross-validation of genes potentially associated with overall survival and drug resistance in ovarian cancer.

    abstract::Ovarian cancer is the leading cause of death among malignancies of the female reproductive system. The 5-year survival rates of ovarian cancer (OC) patients are very poor as a result of recurrent disease and emergence of drug resistance; thus, studies to find predictive markers and factors for drug resistance are ongo...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2017.5534

    authors: Gao Y,Liu X,Li T,Wei L,Yang A,Lu Y,Zhang J,Li L,Wang S,Yin F

    更新日期:2017-05-01 00:00:00

  • Mammary tumors in splenectomized rats.

    abstract::The objective of this study was to examine how splenectomy affects the immune response, particularly T cells, in chemically-induced mammary tumors. Female rats were splenectomized and then exposed to 9,10-dimethyl-1,2-benz(a)anthracene (DMBA) to induce mammary tumors. Splenectomy significantly decreased the rate of tu...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.9.1.185

    authors: Kossoy G,Ben-Hur H,Lifschitz O,Zusman I

    更新日期:2002-01-01 00:00:00

  • TRIM28 knockdown increases sensitivity to etoposide by upregulating E2F1 in non-small cell lung cancer.

    abstract::Tripartite motif containing 28 (TRIM28) is a universal corepressor for Kruppel‑associated box zinc finger proteins. In our previous study, it was shown that expression of TRIM28 is upregulated in non‑small cell lung cancer (NSCLC) cell lines and tissues. Here, we demonstrated that the stable silencing of TRIM28 expres...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2017.5638

    authors: Liu L,Xiao L,Liang X,Chen L,Cheng L,Zhang L,Wu X,Xu Q,Ma C

    更新日期:2017-06-01 00:00:00

  • Detection of activated K-ras in non-small cell lung cancer by membrane array: a comparison with direct sequencing.

    abstract::The ability to detect K-ras oncogene may provide additional information for the management of patients with non-small cell lung cancer (NSCLC). In the present study, we detected the K-ras oncogene in 76 patients with NSCLC by two methods: direct sequencing of K-ras in tumor tissues and membrane array detection of the ...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:

    authors: Chong IW,Chang MY,Sheu CC,Wang CY,Hwang JJ,Huang MS,Lin SR

    更新日期:2007-07-01 00:00:00

  • Reactive oxygen species promote ovarian cancer progression via the HIF-1α/LOX/E-cadherin pathway.

    abstract::Reactive oxygen species (ROS) can drive the de‑differentiation of tumor cells leading to the process of epithelial-to-mesenchymal transition (EMT) to enhance invasion and metastasis. The invasive and metastatic phenotype of malignant cells is often linked to loss of E-cadherin expression, a hallmark of EMT. Recent stu...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2014.3448

    authors: Wang Y,Ma J,Shen H,Wang C,Sun Y,Howell SB,Lin X

    更新日期:2014-11-01 00:00:00

  • EPHX1 polymorphisms do not modify esophageal carcinoma susceptibility in Dutch Caucasians.

    abstract::Esophageal cancer (EC) has a globally increasing incidence with poor curative treatment options and survival rates. Crucial risk factors are exposure to toxins or carcinogens. Microsomal epoxide hydrolase (mEH) is a biotransformation enzyme essential for the detoxification of xenobiotics. Polymorphisms in exon 3 and e...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2012.1734

    authors: Dura P,Bregitha CV,Te Morsche RH,Roelofs HM,Kristinsson JO,Wobbes T,Witteman BJ,Tan AC,Drenth JP,Peters WH

    更新日期:2012-06-01 00:00:00

  • MicroRNA-296 inhibits colorectal cancer cell growth and enhances apoptosis by targeting ARRB1-mediated AKT activation.

    abstract::Colorectal cancer (CRC) is the most commonly diagnosed tumor worldwide. However, the molecular mechanisms and biological processes of CRC remain unknown. The present study used reverse transcription-quantitative polymerase chain reaction to determine the expression levels of microRNA (miR)-296 in CRC cell lines and ti...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2018.6806

    authors: Zhang Z,Zhong X,Xiao Y,Chen C

    更新日期:2019-01-01 00:00:00

  • Growth inhibition and apoptosis of human B-cell lymphoma in vitro and in vivo by Bcl-2 short hairpin RNA.

    abstract::Bcl-2 is overexpressed in various types of human tumors, including Burkitt's lymphoma, and it is involved in tumorigenesis and chemoresistance, therefore, it is regarded as a potential target of gene therapy. In this study, RNA interference using short hairpin RNA (shRNA)-mediated R...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2012.2081

    authors: Liu Y,Shen Y,Qin C,Shi Y,Rong G,Yu X

    更新日期:2013-01-01 00:00:00

  • Exploring the role of glucose‑6‑phosphate dehydrogenase in cancer (Review).

    abstract::Glucose‑6‑phosphate dehydrogenase (G6PD) is a cytoplasmic enzyme found in human erythrocytes that provides reduced NADPH for cell metabolism. Glutathione produced by the G6PD pathway can reduce the degree of harm caused by reactive oxygen species such as oxygen‑containing free radicals, peroxides and lipid peroxides. ...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2020.7803

    authors: Li R,Wang W,Yang Y,Gu C

    更新日期:2020-12-01 00:00:00

  • The novel herbal cocktail MA128 suppresses tumor growth and the metastatic potential of highly malignant tumor cells.

    abstract::MA128, a novel herbal medicine, was previously identified and its effectiveness in the treatment of asthma and atopic dermatitis (AD) was demonstrated. In particular, post-inflammatory hyperpigmentation (PIH) in AD mice was improved by treatment with MA128. In addition, MA128 exhibited anti-melanogenic activity by inh...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2015.4018

    authors: Kim A,Im M,Yim NH,Hwang YH,Yang HJ,Ma JY

    更新日期:2015-08-01 00:00:00

  • The role of MTA1 gene expression in human hepatocellular carcinoma.

    abstract::The MTA1 gene has been identified as metastasis-associated gene and has been seen to correlate with the degree of invasion and lymphatic metastasis in gastric, colorectal, and esophageal carcinomas. We investigated the possible role of MTA1 gene expression in hepatocellular carcinoma (HCC). The mRNA expression level o...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:

    authors: Hamatsu T,Rikimaru T,Yamashita Y,Aishima S,Tanaka S,Shirabe K,Shimada M,Toh Y,Sugimachi K

    更新日期:2003-05-01 00:00:00

  • Significance of Lysyl oxidase‑like 2 gene expression on the epithelial‑mesenchymal status of hepatocellular carcinoma.

    abstract::In the present study, we investigated the role of lysyl oxidase‑like 2 (LOXL2), the correlation between LOXL2 and epithelial to mesenchymal transition (EMT) and the effects of using β‑aminopropionitrile (BAPN) to inhibit LOXL2 with the aim of reducing tumor progression in hepatocellular carcinoma (HCC). The expression...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2018.6349

    authors: Ninomiya G,Yamada S,Hayashi M,Takeda S,Suenaga M,Takami H,Kanda M,Iwata N,Niwa Y,Tanaka C,Kobayashi D,Fujii T,Nakayama G,Sugimoto H,Koike M,Fujiwara M,Kodera Y

    更新日期:2018-06-01 00:00:00

  • Mechanism of the inhibition of the STAT3 signaling pathway by EGCG.

    abstract::Signal transducer and activator of transcription 3 (STAT3) is an oncogene that promotes cell survival, proliferation, and motility. In the present study, we explored the mechanism involved in the inhibition by epigallocatechin-3-gallate (EGCG) of STAT3 signaling as detected by surface plasmon resonance (SPR)-binding a...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2013.2743

    authors: Wang Y,Ren X,Deng C,Yang L,Yan E,Guo T,Li Y,Xu MX

    更新日期:2013-12-01 00:00:00

  • Classification of neural differentiation-associated genes in P19 embryonal carcinoma cells by their expression patterns induced after cell aggregation and/or retinoic acid treatment.

    abstract::Expression of neural differentiation-associated genes was examined by RT-PCR and macroarray analyses during neural differentiation of P19 embryonal carcinoma cells induced by cell aggregation and/or retinoic acid (RA) treatment. Results revealed that the neural genes examined could be classified into 4 groups based on...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:

    authors: Teramoto S,Kihara-Negishi F,Sakurai T,Yamada T,Hashimoto-Tamaoki T,Tamura S,Kohno S,Oikawa T

    更新日期:2005-11-01 00:00:00

  • miR-375 inhibits the invasion and metastasis of colorectal cancer via targeting SP1 and regulating EMT-associated genes.

    abstract::Accumulating evidence has shown that aberrantly expressed microRNAs (miRNAs) are associated with tumor development and progression. Our previous study found that microRNA-375 (miR-375) was downregulated in colorectal cancer (CRC), but little is known concerning the role of miR-375 and the related mechanism in CRC deve...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2016.4834

    authors: Cui F,Wang S,Lao I,Zhou C,Kong H,Bayaxi N,Li J,Chen Q,Zhu T,Zhu H

    更新日期:2016-07-01 00:00:00

  • Downregulation of IDH2 exacerbates the malignant progression of osteosarcoma cells via increased NF-κB and MMP-9 activation.

    abstract::Isocitrate dehydrogenase 2 (IDH2) is a mitochondrial NADP-dependent isocitrate dehydrogenase. It is considered to be a novel tumor suppressor in several types of tumors. However, the role and related mechanism of IDH2 in osteosarcoma remain unknown. The expression and significance of IDH2 were investigated by immunohi...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2016.4553

    authors: Yi WR,Li ZH,Qi BW,Ernest ME,Hu X,Yu AX

    更新日期:2016-04-01 00:00:00

  • Ginsenoside Rg3 induces apoptosis in the U87MG human glioblastoma cell line through the MEK signaling pathway and reactive oxygen species.

    abstract::Ginsenoside is known to have potential cancer-preventive activities. The major active components in red ginseng consist of a variety of ginsenosides including Rg3, Rg5 and Rk1, each of which has different pharmacological activities. Among these, Rg3 has been reported to exert anticancer activities through inhibition o...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2013.2555

    authors: Choi YJ,Lee HJ,Kang DW,Han IH,Choi BK,Cho WH

    更新日期:2013-09-01 00:00:00

  • Overexpression of IL-9 induced by STAT3 phosphorylation is mediated by miR-155 and miR-21 in chronic lymphocytic leukemia.

    abstract::Interleukin‑9 (IL‑9) can function as both a positive and negative regulator of immune response, however the role of IL‑9 in tumor immunity is poorly understood. Chronic lymphocytic leukemia (CLL) is the most common chronic lympho‑proliferative disorder. Twenty CLL patients from 2010 to 2011 were recruited in the study...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2018.6367

    authors: Chen N,Feng L,Qu H,Lu K,Li P,Lv X,Wang X

    更新日期:2018-06-01 00:00:00

  • Relationship between peroxisome proliferator-activated receptor-gamma expression and differentiation of human esophageal squamous cell carcinoma.

    abstract::Peroxisome proliferator-activated receptor-gamma (PPAR-gamma), a member of the nuclear hormone receptor superfamily, is involved in suppressing the growth of several tumors. We showed that PPAR-gamma is expressed in Barrett's adenocarcinoma cell lines and inhibited the growth of these lines through the induction of G1...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:

    authors: Takashima T,Fujiwara Y,Hamaguchi M,Sasaki E,Tominaga K,Watanabe T,Oshitani N,Higuchi K,Arakawa T

    更新日期:2005-04-01 00:00:00

  • Epstein-Barr virus-associated gastric carcinoma in Cali, Colombia.

    abstract::To estimate the incidence of Epstein-Barr virus-associated gastric carcinoma (EBV-GC) in Colombia and to clarify its clinicopathological features, we examined 178 consecutive gastric carcinoma cases, diagnosed during the period from 1996 to 1998, at Hospital Universitario del Valle in Cali, Colombia. The mean age of t...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:

    authors: Carrascal E,Koriyama C,Akiba S,Tamayo O,Itoh T,Eizuru Y,Garcia F,Sera M,Carrasquilla G,Piazuelo MB,Florez L,Bravo JC

    更新日期:2003-07-01 00:00:00

  • Pharmacological inhibition of Rho-kinase signaling with Y-27632 blocks melanoma tumor growth.

    abstract::Primarily through in vitro studies, the Rho-family of small GTPases and their effector proteins have been implicated in mediating oncogenic properties of cancer cells. We sought to determine if pharmacological inhibition of the RhoA effector proteins known as Rho-kinases (ROCK) with the small molecule inhibitor Y-2763...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:

    authors: Routhier A,Astuccio M,Lahey D,Monfredo N,Johnson A,Callahan W,Partington A,Fellows K,Ouellette L,Zhidro S,Goodrow C,Smith A,Sullivan K,Simone P,Le L,Vezuli B,Zohni M,West E,Gleason D,Bryan B

    更新日期:2010-03-01 00:00:00

  • Overexpression of IC53d promotes the proliferation of gastric cancer cells by activating the AKT/GSK3β/cyclin D1 signaling pathway.

    abstract::Cyclin‑dependent kinase 5 regulatory subunit‑​associated protein 3 (CDK5RAP3 or C53) is involved in the development of various types of tumor, and alternative splicing of C53 results in numerous transcription variants that encode different isoforms. The present study aimed to clone human C53 isoform d (IC53d) and expl...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2019.7042

    authors: Lin JX,Xie XS,Weng XF,Qiu SL,Xie JW,Wang JB,Lu J,Chen QY,Cao LL,Lin M,Tu RH,Li P,Huang CM,Zheng CH

    更新日期:2019-05-01 00:00:00

  • MicroRNA-154 functions as a tumor suppressor in osteosarcoma by targeting Wnt5a.

    abstract::MicroRNAs (miRNAs) are small non-coding RNAs that are involved in tumor initiation and development by suppressing target gene expression. miRNA-154 has been shown to be important in tumorigenesis in many types of cancers. However, its role in osteosarcoma (OS) remains unknown. In the present study, we focused on the r...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2015.4495

    authors: Zhou H,Zhang M,Yuan H,Zheng W,Meng C,Zhao D

    更新日期:2016-03-01 00:00:00

  • Epithelial membrane protein 1 promotes glioblastoma progression through the PI3K/AKT/mTOR signaling pathway.

    abstract::Glioblastoma multiforme (GBM) is the most malignant intracranial tumor. Although the affected patients are usually treated with surgery combined with radiotherapy and chemotherapy, the median survival time for GBM patients is still approximately 12‑14 months. Identifying the key molecular mechanisms and targets of GBM...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2019.7204

    authors: Miao L,Jiang Z,Wang J,Yang N,Qi Q,Zhou W,Feng Z,Li W,Zhang Q,Huang B,Chen A,Zhang D,Zhao P,Li X

    更新日期:2019-08-01 00:00:00

  • Does dexamethasone inhibit anticancer activity of cetuximab in squamous cell carcinoma cell lines of the head and neck?

    abstract::Glucocorticoids such as dexamethasone are widely used as comedication in the treatment of head and neck cancer, e.g., to improve appetite and decrease weight loss and fatigue in patients with advanced disease or as antiallergic and antiemetic prophylaxis during anti-EGFR therapy. However, the literature suggests that ...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or_00000421

    authors: Wagenblast J,Baghi M,Mörtel S,Hirth D,Thron L,Arnoldner C,Gstöttner W,May A,Hambek M

    更新日期:2009-07-01 00:00:00